Oncology - European Medical Journal

Continue

Oncology

Filter
5 Dec 2017

Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint® BluePrint® Breast Cancer Kit Co-Validation Study

Agendia, a world leader in personalized medicine and molecular cancer diagnostics, and Institute Curie in Paris, France…
1 Dec 2017

New Data at the San Antonio Breast Cancer Symposium Demonstrate the Value of MammaPrint® and BluePrint® Across Breast Cancer Patient Populations

Irvine, CA, USA and Amsterdam, the Netherlands, 30 November, 2017 – Agendia, Inc., a world leader in personalized medicine…
1 Dec 2017

Eye Contact Establishes Brainwave Synchronisation Between Adults and Babies

BRAINWAVES of adults and babies are synchronised when eye contact is made between the two, which is likely to enhance communication and learning…
30 Nov 2017

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

Prague, Czech Republic, 28 November, 2017 – SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient…
23 Nov 2017

Treatment Approval Broadened to Include Earlier Stage Prostate Cancer Patients

AN UNMET need in prostate cancer patients could be filled following the extension of European Commission (EC) marketing authorisation of the combination…
13 Nov 2017

Significant Mortality Benefits of Mechanical Valves

MECHANICAL valves have very good long-term mortality benefits and should be used more often, particularly in younger patients who require mitral-valve…
30 Oct 2017

Call for Greater Cancer Clinical Trial Eligibility

RECOMMENDATIONS for wider eligibility criteria for cancer clinical trials are being voiced by The American Society of Clinical Oncology (ASCO) and…
24 Oct 2017

Introducing EMJ Oncology 5.1

United Kingdom, October 24, 2017: Welcome to this year’s issue of EMJ Oncology, which is filled with the latest developments from the world of cancer…
We’ve noticed you’re accessing
from North/South America.